IMARC Group has recently released a new research study “Endoscopic Retrograde Cholangiopancreatography Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of the Endoscopic Retrograde Cholangiopancreatography Industry?
The global endoscopic retrograde cholangiopancreatography market size reached US$ 1.38 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.11 Billion by 2027, exhibiting a growth rate (CAGR) of 7.20% during 2022-2027.
What is a Endoscopic Retrograde Cholangiopancreatography?
Endoscopic retrograde cholangiopancreatography (ERCP) represents an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, pancreas, etc. It combines X-rays and a long, flexible, lightweight endoscope tube that passes via the esophagus, mouth, and stomach. ERCP aids in detecting blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct.
It is a less invasive procedure than open surgery and provides more detailed and accurate information regarding the pancreaticobiliary system. Consequently, endotherapy devices are extensively utilized to investigate dysphagia, diarrhea, weight loss, heartburn, stool blood, etc.
Impact of COVID-19:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request and get a sample brochure for free: https://www.imarcgroup.com/endoscopic-retrograde-cholangiopancreatography-market/requestsample
What are the major market drivers in the Endoscopic Retrograde Cholangiopancreatography market?
The expanding global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett's disease, biliary, liver, Crohn's, inflammatory bowel and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), are primarily augmenting the endoscopic retrograde cholangiopancreatography market.
Furthermore, the increasing incidences of the benign pancreas and liver tumors are positively influencing the global market. Apart from this, the growing number of hospitals and diagnostic centers is propelling the need for imaging techniques, which is acting as another significant growth-inducing factor.
Moreover, government bodies and healthcare organizations across numerous countries are investing in advanced endoscopy devices and improved endoscopy research, which is also bolstering the market growth. Besides this, the elevating consumer inclination towards minimally invasive surgeries for a speedy recovery and minimal pain is further catalyzing the global market. Additionally, continuous improvements in healthcare infrastructures and the emerging trend of medical tourism are expected to fuel the endoscopic retrograde cholangiopancreatography market in the coming years.
| Endoscopic Retrograde Cholangiopancreatography Market Report Scope | |
| Report Coverage | Details |
| Market size value in 2021 | US$ 1.38 Billion |
| Market forecast in 2027 | US$ 2.11 Billion |
| Growth Rate | CAGR of 7.20% from 2022 to 2027 |
| Base year for estimation | 2021 |
| Historical data | 2016-2021 |
| Forecast period | 2022-2027 |
| Report coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends |
| Segments covered | Product, Procedure And End User |
| Regional scope | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Key companies profiled | Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc. |
| Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Endoscope
- Endotherapy Devices
- Sphincterotomes
- Lithotripter
- Stents
- Others
- Visualization Systems
- Energy Devices
- Others
Breakup by Procedure:
- Biliary Sphincterotomy
- Biliary Stenting
- Biliary Dialtation
- Pancreatic Sphincterotomy
- Pancreatic Duct Stenting
- Pancreatic Duct Dilatation
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Others
By Geography:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
The major players in the market are
- Boston Scientific Corporation
- CONMED Corporation
- Cook Group Incorporated
- Fujifilm Holdings Corporation
- Hobbs Medical Inc.
- Johnson & Johnson
- Medi-Globe GmbH
- Medtronic plc
- Olympus Corporation
- Shaili Endoscopy
- Steris Corporation
- and Telemed Systems Inc.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800